Browse the corpus
Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.
1 passage
REFERENCES Allegra CJ, Lakomy R, Tabernero J, et al, “Effects of Prior Bevacizumab (B) Use on Outcomes From the VELOUR Study: A Phase III Study of Aflibercept (Afl) and FOLFIRI in Patients (Pts) With Metastatic Colorectal Cancer (Mcrc) After Failure of an Oxaliplatin Regimen,” J Clin Oncol , 2012, 30(15s):3505 [abstract 3505 from ASCO 2012 Annual Meeting]. Gaya A and Tse V, “A Preclinical and Clinical Review of Aflibercept for the Management of Cancer,” Cancer Treat Rev , 2012, 38(5):484-93. [PubMed 22264850 ] Isambert N, Freyer G, Zanetta S, et al, “Phase I Dose-Escalation Study of Intravenous Aflibercept in Combination With Docetaxel in Patients With Advanced Solid Tumors,” Clin Cancer Res , 2012, 18(6):1743-50. [PubMed 22261804 ] Joulian F, Van Cutsem E, Iqbal SU, et al, “Aflibercept versus Placebo in Combination With FOLFIRI in Previously Treated Metastatic Colorectal Cancer (Mcrc): Mean Overall Survival (OS) Estimation From a Phase III Trial (VELOUR),” J Clin Oncol , 2012, 30(15s):3602 [abstract 3602 from ASCO 2012 Annual Meeting]. Lockhart AC, Rothenberg ML, Dupont J, et al, “Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors,” J Clin Oncol , 2010, 28(2):207-14. [PubMed 19949018 ] Tabernero J, Allegra CJ, Rougier PR, et al, “ Meta-Analysis of Anti-VEGF Class Adverse Events From Three Double-Blind (db) Placebo (pbo)-Controlled Phase III Trials With IV Aflibercept (Afl),” J Clin Oncol , 2012, 30(15s):3579 [abstract 3579 from ASCO 2012 Annual Meeting]. Van Cutsem E, Tabernero J, Lakomy R, et al, "Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen," J Clin Oncol , 2012, 30(28):3499-506. [PubMed 22949147 ] Topic 86239 Version 12.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0504-125.39.66.147-41275854C3-S244013.14]